yingweiwo

FAP

FAP

FAP related products

Structure Cat No. Product Name CAS No. Product Description
Cys-FAP targeting peptide for FXX489 TFA V133087 Cys-FAP targeting peptide for FXX489 TFA Cys-FAP targeting peptide for FXX489 TFA is the unlabeled peptide moiety of FXX489.
DOTA-ALB-02 V119214 DOTA-ALB-02 DOTA-ALB-02 is an albumin-bound FAP inhibitor (FAPI) ligand.
DOTAGA.(SA.FAPi)2 TFA V94503 DOTAGA.(SA.FAPi)2 TFA DOTAGA.(SA.FAPi)2 TFA is a potent inhibitor of dimeric fibroblast activation protein (FAPi).
FAP-IN-6 V135787 FAP-IN-6 FAP-IN-6 is a selective FAP inhibitor with an IC50 value of 13 pM.
FAPI-46 V51734 FAPI-46 2374782-04-2 FAPI-46 is a quinoline-based activator of fibroblast-activated protein (FAP).
Fluorogen binding modulator-1 V74895 Fluorogen binding modulator-1 510716-65-1 Fluorogen binding modulator-1 (PubChem SID 125240934) is a fluorescein-activated protein (FAP)-fluorogen binding modulator with a -log EC50 of 6.61 for AM2.2-β2AR and AM2.2-gpr32 respectively.
NOTA-SP2A-FAPT V141582 NOTA-SP2A-FAPT NOTA-SP2A-FAPT is a fibroblast activation protein (FAP) ligand.
QI-18 V143653 QI-18 3093894-38-0 QI-18 is an inhibitor of fibroblast activating protein (FAP) with an IC50 value of 0.50 nM, which is 6.5 times more potent than UAMC-1110 (4, IC50 value 3.25 nM).
Rofapitide tetraxetan acetate V144269 Rofapitide tetraxetan acetate Rofapitide tetraxetan acetate is a highly efficient and selective FAP-binding peptide with an average IC50 value of 2.7 nM for binding to FAP.
TriOncoFAP-GlyPro-MMAE V146497 TriOncoFAP-GlyPro-MMAE TriOncoFAP-GlyPro-MMAE is a small molecule drug conjugate (SMDC) targeting fibroblast activating protein (FAP) with an IC50 of 13 pmol/L.
Unlabeled FXX489 V146773 Unlabeled FXX489 3076330-05-4 Unlabeled FXX489 is a fibroblast activation protein (FAP) targeting ligand.
Zilganersen sodium scrambled negative control V147342 Zilganersen sodium scrambled negative control The Zilganersen sodium scrambled negative control is a negative control with the sequence of Zilganersen sodium scrambled.
Contact Us